Medivation Inc (MDVN)

80.27
NASDAQ : Health Care
Prev Close 80.27
Day Low/High 0.00 / 0.00
52 Wk Low/High 26.41 / 80.67
Avg Volume 2.76M
Exchange NASDAQ
Shares Outstanding 165.93M
Market Cap 13.34B
EPS 1.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Medivation (MDVN) Stock Downgraded After Pfizer Deal

Medivation (MDVN) Stock Downgraded After Pfizer Deal

Medivation's (MDVN) stock rating was cut by several firms on Tuesday morning after the company agreed to be acquired by Pfizer (PFE) for $14 billion yesterday.

Jim Cramer's 'Mad Money' Recap: I'm Watching Best Buy, PVH, Yellen This Week

Jim Cramer's 'Mad Money' Recap: I'm Watching Best Buy, PVH, Yellen This Week

Earnings season is far from over, Cramer says, and the Fed chief gives a major speech Friday.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

Market Keeps Chasing Its Own Tail

Stocks travel a good distance just to end up nowhere.

Stocks Waver as Investors Wait for Fed Clarity

Stocks Waver as Investors Wait for Fed Clarity

Wall Street will get more clues on the Fed's rate hike plans later this week, but uncertainty over what they might be led to jittery trading on Monday.

Stocks Struggle for Direction as Jackson Hole Conference Looms

Stocks Struggle for Direction as Jackson Hole Conference Looms

Stocks fluctuate Monday afternoon as a selloff in crude oil hits the energy sector and Federal Reserve speeches at the end of the week leave investors wary.

Medivation, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Merger With Pfizer Inc.

Medivation, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Merger With Pfizer Inc.

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Medivation, Inc.

Medivation Scores Premium in Sale to Pfizer

Medivation Scores Premium in Sale to Pfizer

Shareholders of the oncology drug maker ought to be satisfied with the auction's conclusion.

Cramer: A Bunch of Semis Are Ripe for the Picking

Cramer: A Bunch of Semis Are Ripe for the Picking

That's the hot spot in M&A right now.

Pfizer's Deal to Buy Medivation May Give the Company Its Groove Back

Pfizer's Deal to Buy Medivation May Give the Company Its Groove Back

Pfizer's $14 billion acquisition of Medivation is a strong purchase, according to Jim Cramer, who now wonders what Sanofi will do next.

Crude Selloff, Health Care Rally Split Wall Street

Crude Selloff, Health Care Rally Split Wall Street

Stocks fluctuate on Monday as doubts over a production freeze agreement from major oil-producing countries snapped crude oil's recent rally.

Pfizer to Pick Up Medivation in All-Cash Deal

PFE is trading up on the announcement, and the deal should add to earnings in 2017.

Facebook Stands Out and FormFactor Has a Good Start

Facebook Stands Out and FormFactor Has a Good Start

Overall, this is still a good environment for stock picking.

More Squawk from Jim Cramer: Pfizer Buys Medivation (MDVN) for $14 Billion

More Squawk from Jim Cramer: Pfizer Buys Medivation (MDVN) for $14 Billion

The deal is 'very healthy' for the biopharma group, according to TheStreet's Jim Cramer.

Pfizer Is Buying Medivation for $14 Billion

Pfizer Is Buying Medivation for $14 Billion

Pfizer confirmed its $14 billion acquisition of cancer drugmaker Medivation on Monday.

Stock Futures Slide as Crude's Winning Streak Is Snapped

Stock Futures Slide as Crude's Winning Streak Is Snapped

Stock futures move lower on Monday as doubts over a production freeze agreement from major oil-producing countries leave crude oil in the lurch.

Morning Movers: PFE, VRX, VIAB, FL, UA

Morning Movers: PFE, VRX, VIAB, FL, UA

Pfizer agrees to acquire Medivation while Citi puts Foot Locker and Under Armour on the back-to-school shopping list.

Pfizer Buys Medivation, the Crown Jewel in Cancer Therapy

Pfizer Buys Medivation, the Crown Jewel in Cancer Therapy

A potential blockbuster drug deal is reportedly in the works.

5 Things You Must Know Before the Market Opens Monday

5 Things You Must Know Before the Market Opens Monday

Pfizer finalizes a deal to buy cancer drugmaker Medivation; ChemChina gets U.S. approval for its takeover of Syngenta; Viacom CEO Philippe Dauman is ousted.

Pfizer Confirms $14 Billion Takeover of Cancer Drugmaker Medivation

Pfizer Confirms $14 Billion Takeover of Cancer Drugmaker Medivation

Acquiring Medivation will strengthen Pfizer's oncology franchise, which has lost ground in recent years to some Big Pharma competitors.

Pfizer To Acquire Medivation

Pfizer To Acquire Medivation

Pfizer Inc. (NYSE:PFE) and Medivation, Inc.

What CVS and Express Scripts' Drug Exclusion Lists Means for Your Portfolio

What CVS and Express Scripts' Drug Exclusion Lists Means for Your Portfolio

Earlier this month the two major pharmacy benefit managers, CVS Caremark CVS and Express Scripts ESRX released lists of drugs they will no longer cover in 2017.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AOSL, ARES, BREW, CHTR, FSIC, GBDC, IPAR, LUK, LUNA, NRCIA, ODP, OLED, PIP, STRL, VIPS Downgrades: BCRH, CBNK, DF, HALL, MDVN, MYGN, NMR, NYRT, SGU, TCRD, TEO Initiations: APPF, GLPI, SPNE, TDOC Read on to get TheStreet Quant Ratings' detailed report:

Analysts' Actions -- Coach, SunPower, Wayfair, Yelp and More

Analysts' Actions -- Coach, SunPower, Wayfair, Yelp and More

Here are Wednesday's top research calls, including upgrades for Coach and Yelp, and downgrades for SunPower and Wayfair.

Medivation (MDVN) Stock Sliding in After-Hours Trading on Q2 Revenue Miss

Medivation (MDVN) Stock Sliding in After-Hours Trading on Q2 Revenue Miss

Medivation (MDVN) stock was down in after-hours trading after the company posted lower-than-expected second quarter revenues.

Biotech Pop-Up Party in Full Swing

Biotech Pop-Up Party in Full Swing

The beaten-down biotech sector is making an impressive comeback. The sector seems to be rebounding after tumbling by more than 40%.

It's 'All Systems Go' for Biotech

It's 'All Systems Go' for Biotech

The sector seems to be rebounding after tumbling by more than 40%.